Ultralife ULBI

Ultralife reports strong Q3 2026 results

Ultralife (ULBI) filed an 8-K with the SEC on Nov 9, 2026, 3:38 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Sales of $48.3 million, up 11.3% from $43.4 million in Q3 2025
  2. Gross profit of $13.3 million, or 27.5% of revenue, compared to $9.6 million in Q3 2025
  3. GAAP EPS of $0.14, up from ($0.07) in Q3 2025
  4. Backlog of $136.0 million, the highest in company history

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get an email when Ultralife files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.